Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells
- PMID: 9200481
Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells
Abstract
Induction of indoleamine 2,3-dioxygenase (IDO) and nitric oxide synthase (NOS) is involved in the immunomodulatory roles of IFN-gamma and evidence suggests that these pathways are functionally cross-regulated. We report here that nitric oxide (NO) negatively modulates the expression of IDO activity in IFN-gamma-primed macrophages, but not in microglial cells from mouse. In MT2 macrophages, the induction of IDO activity by IFN-gamma was further increased by the presence of NOS inhibitors, whereas culturing of IFN-gamma-activated MT2 cells with NO generators produced a marked reduction of IDO activity expression. Conversely, neither NOS inhibitors nor exogenous NO affected the induction of the enzyme activity in N11 microglial cells after IFN-gamma activation. LPS and picolinic acid, two costimulatory agents that up-regulate inducible NOS in activated cells, regulated IDO induction differently in the two cell lines. LPS and picolinic acid caused a significant decrease of IDO activity in IFN-gamma-activated MT2 cells. This effect, however, did not appear to be mediated by the ability of LPS and picolinic acid to stimulate NO production. In N11 cells, LPS further stimulated the enzyme activity and picolinic acid had no effect. Northern blot analysis revealed that, in MT2 macrophages, NOS inhibitors increased the levels of IDO mRNA, while a reduction was observed with picolinic acid. No changes in IDO mRNA levels were detected in N11 cells. Consistent with the functional heterogeneity of phagocytes, the reported results indicate the existence of marked differences in the regulation of IDO expression between murine macrophages and microglial cells.
Similar articles
-
Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-gamma-activated macrophages.J Leukoc Biol. 2000 Aug;68(2):260-6. J Leukoc Biol. 2000. PMID: 10947071
-
Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators.Amino Acids. 1998;14(1-3):251-5. doi: 10.1007/BF01345271. Amino Acids. 1998. PMID: 9871470
-
Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.Int J Oncol. 2008 Mar;32(3):713-21. Int J Oncol. 2008. PMID: 18292949
-
Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.Ann N Y Acad Sci. 2007 Dec;1122:35-49. doi: 10.1196/annals.1403.003. Ann N Y Acad Sci. 2007. PMID: 18077563 Review.
-
IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism.Adv Exp Med Biol. 1999;467:517-24. doi: 10.1007/978-1-4615-4709-9_64. Adv Exp Med Biol. 1999. PMID: 10721095 Review.
Cited by
-
Kynurenine Pathway in Chronic Kidney Disease: What's Old, What's New, and What's Next?Int J Tryptophan Res. 2020 Sep 21;13:1178646920954882. doi: 10.1177/1178646920954882. eCollection 2020. Int J Tryptophan Res. 2020. PMID: 35210786 Free PMC article. Review.
-
Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma.Antioxidants (Basel). 2022 Feb 4;11(2):315. doi: 10.3390/antiox11020315. Antioxidants (Basel). 2022. PMID: 35204197 Free PMC article.
-
Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through GAPDH- and Hsp90-dependent control of their heme levels.Free Radic Biol Med. 2022 Feb 20;180:179-190. doi: 10.1016/j.freeradbiomed.2022.01.008. Epub 2022 Jan 17. Free Radic Biol Med. 2022. PMID: 35051612 Free PMC article.
-
Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease.Oxid Med Cell Longev. 2020 Dec 29;2020:6656033. doi: 10.1155/2020/6656033. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33456671 Free PMC article. Review.
-
Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism.Int J Mol Sci. 2020 Nov 18;21(22):8705. doi: 10.3390/ijms21228705. Int J Mol Sci. 2020. PMID: 33218054 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials